Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.38 |
| ▸ | TK1 | P04183 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30425720 | 0.86 | TSHR (0.61) | TSHRKMT2AALOX5TK1ALDH1A1 | |
| SCHEMBL76044 | 0.86 | TSHR (0.61) | TSHRKMT2AALOX5TK1ALDH1A1 | |
| SCHEMBL7949742 | 0.84 | TSHR (0.42) | TSHRMAPTKMT2AMEN1TAAR1 | |
| SCHEMBL22160794 | 0.84 | TSHR (0.58) | TSHRKMT2AALOX5TK1ALDH1A1 | |
| Phenylacetaldehyde SCHEMBL217860 | 0.80 | TAAR1 (0.43) | TSHRMAPTKMT2AHTTMEN1 | |
| Methylene Chloride SCHEMBL29153178 | 0.80 | TSHR (0.54) | TSHRALOX5TK1ALDH1A1CA1 | |
| SCHEMBL2281945 | 0.77 | TSHR (0.54) | TSHRHTTALDH1A1 | |
| Acetic Acid SCHEMBL12274807 | 0.77 | ALDH1A1 (0.49) | TSHRMAPTALOX5ALDH1A1 | |
| SCHEMBL12274808 | 0.76 | SLC1A1 (0.48) | TSHRMAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL27172833 | 0.75 | TSHR (0.52) | TSHRHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010053852-A1 | Process for preparing alkyl- or aryloxyacetaldehydes | DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) | 2001-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010053852-A1 | Process for preparing alkyl- or aryloxyacetaldehydes | ARSA, AOC2, AKR7A2 | TSHR 1363/4885MAPT 4617/4885KMT2A 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.